Texas Top Legal Officer Sues Tylenol Makers Over Autism Allegations

Legal Action
Ken Paxton, who supports former President Trump who is running for the United States Senate, alleged pharmaceutical manufacturers of hiding safety concerns of acetaminophen

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the corporations hid safety concerns that the medication created to pediatric cognitive development.

This legal action follows four weeks after Former President Trump promoted an unsubstantiated connection between using acetaminophen - also known as paracetamol - while pregnant and autism in offspring.

Paxton is filing suit against J&J, which formerly manufactured the drug, the only pain reliever approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "deceived the public by gaining financially from pain and marketing drugs regardless of the potential hazards."

Kenvue says there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These corporations deceived for years, deliberately risking millions to line their pockets," the attorney general, a Republican, declared.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the welfare of American women and children."

On its official site, Kenvue also stated it had "consistently assessed the pertinent research and there is no credible data that indicates a verified association between consuming acetaminophen and autism."

Organizations acting on behalf of doctors and healthcare providers agree.

ACOG has stated acetaminophen - the main ingredient in Tylenol - is one of the few options for pregnant women to address pain and fever, which can pose significant medical dangers if ignored.

"In multiple decades of studies on the use of paracetamol in pregnancy, zero credible investigations has definitively established that the consumption of paracetamol in any stage of gestation leads to neurological conditions in young ones," the association stated.

The lawsuit mentions current declarations from the Trump administration in asserting the medication is reportedly hazardous.

Last month, Trump caused concern from public health officials when he advised women during pregnancy to "fight like hell" not to consume Tylenol when unwell.

The US Food and Drug Administration then published an announcement that medical professionals should think about restricting the usage of Tylenol, while also declaring that "a causal relationship" between the medication and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to undertake "comprehensive study program" that would identify the cause of autism in a matter of months.

But specialists cautioned that discovering a sole reason of autism - thought by researchers to be the outcome of a complex mix of genetic and environmental factors - would be difficult.

Autism is a form of lifelong neurodivergence and impairment that impacts how individuals perceive and engage with the environment, and is recognized using physician assessments.

In his court filing, Paxton - a Trump ally who is campaigning for the Senate - alleges the manufacturer and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the firms "destroy any commercial messaging" that states acetaminophen is reliable for expectant mothers.

The court case mirrors the grievances of a collection of guardians of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

The court threw out the lawsuit, saying studies from the parents' expert witnesses was not conclusive.

Joseph Herring
Joseph Herring

Lena is a tech enthusiast and writer with a passion for exploring how emerging technologies shape our daily lives and future possibilities.